Nucleoside Metabolic Inhibitor

17 marketed 1 in Phase 2

This page covers all Nucleoside Metabolic Inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Carbonic anhydrase 5A, mitochondrial, Adenosine deaminase, DNA polymerase (alpha/delta/epsilon).

Targets

Carbonic anhydrase 5A, mitochondrial · Adenosine deaminase · DNA polymerase (alpha/delta/epsilon) · Thymidylate synthase · DNA methyltransferase · Ribonucleotide reductase; DNA incorporation · Ribonucleoside-diphosphate reductase large subunit · Aromatase · DNA (cytosine-5)-methyltransferase 1 · Cytidine deaminase

Marketed (17)

Phase 2 pipeline (1)

Patent intelligence